ArticleHepatology (Baltimore, Md.)2011
Is it the end of the line for the EMT?
Article in Hepatology (Baltimore, Md.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Exploring the role of EMT in ovarian cancer progression using a multiscale mathematical model.NPJ systems biology and applications · 2025Article
- Lack of basic rationale in epithelial-mesenchymal transition and its related concepts.Cell & bioscience · 2024Review
- Article
- Can a fibrotic liver afford epithelial-mesenchymal transition?World journal of gastroenterology · 2017Review
- Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma.International journal of molecular sciences · 2017Review
- HDAC1 promoted migration and invasion binding with TCF12 by promoting EMT progress in gallbladder cancer.Oncotarget · 2016Article
- Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the "Reactive" Biliary Epithelial Phenotype.Stem cells international · 2016Review
- Esophageal epithelial cells acquire functional characteristics of activated myofibroblasts after undergoing an epithelial to mesenchymal transition.Experimental cell research · 2015Article
- Evidence for and against epithelial-to-mesenchymal transition in the liver.American journal of physiology. Gastrointestinal and liver physiology · 2013Article
- Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma.Hepatology (Baltimore, Md.) · 2013Article
- Contribution of Myofibroblasts of Different Origins to Liver Fibrosis.Current pathobiology reports · 2013Article
- Unveiling the role of tumor reactive stroma in cholangiocarcinoma: an opportunity for new therapeutic strategies.Translational gastrointestinal cancer · 2013Article
- Macrophage secretory products induce an inflammatory phenotype in hepatocytes.World journal of gastroenterology · 2012Article
- Cell signals influencing hepatic fibrosis.International journal of hepatology · 2012Article
- Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches.Chemico-biological interactions · 2011Review
- Myofibroblast differentiation and survival in fibrotic disease.Expert reviews in molecular medicine · 2011Review
- Liver fibrosis: Our evolving understanding.Clinical liver diseaseReview
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
21433040What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.